Table 1.
Characteristics of Respondents (n = 61).
|
| ||||
|---|---|---|---|---|
| CHARACTERISTIC | ALL (N = 61) | HIC (N = 36) | LMIC (N = 25) | P VALUE |
|
| ||||
| Gender± | ||||
|
| ||||
| Female | 35 (58.3%)¥ | 27 (75.0%) | 8 (33.3%) | 0.001a |
|
| ||||
| Male | 25 (41.7%)¥ | 9 (25.0%) | 16 (66.7%) | |
|
| ||||
| Training Stage | ||||
|
| ||||
| Post-doctoral | 45 (73.8%) | 28 (77.8%) | 17 (68.0%) | 0.393a |
|
| ||||
| Pre-doctoral | 16 (26.2%) | 8 (22.2%) | 8 (32.0%) | |
|
| ||||
| Degree Status at Time of UJMT Program | ||||
|
| ||||
| Already had MD | 28 (45.9%) | 15 (41.7%) | 13 (52.0%) | 0.095b |
|
| ||||
| Already had PhD | 9 (14.6%) | 4 (11.1%) | 5 (20.0%) | |
|
| ||||
| Pursuing MD | 7 (11.5%) | 7 (19.4%) | 0 (0.0%) | |
|
| ||||
| Pursuing PhD | 17 (27.9%) | 10 (27.8%) | 7 (28.0%) | |
|
| ||||
| Area of Study at time of UJMT Program | ||||
|
| ||||
| Basic Science | 12 (19.7%) | 10 (27.8%) | 2 (8.0%) | 0.099b |
|
| ||||
| Secondary Data Analysis | 13 (21.3%) | 9 (25.0%) | 4 (16.0%) | 0.399a |
|
| ||||
| Clinical Trial | 11 (18.0%) | 8 (22.2%) | 3 (12.0%) | 0.500b |
|
| ||||
| Public Health/Health Education | 30 (49.2%) | 19 (52.8%) | 11 (44.0%) | 0.500a |
|
| ||||
| Implementation Science | 11 (18.3%) | 2 (5.6%) | 9 (36.0%) | 0.005b |
|
| ||||
| Prior Experiences in Global Health Training | ||||
|
| ||||
| Never | 13 (21.3%) | 2 (5.6%) | 11 (44.0%) | <0.001b |
|
| ||||
| 1–2 | 26 (42.6%) | 17 (47.2%) | 9 (36.0%) | |
|
| ||||
| 3–5 | 14 (23.0%) | 13 (36.1%) | 1 (4.0%) | |
|
| ||||
| More than 5 | 8 (13.1%) | 4 (11.1%) | 4 (16.0%) | |
|
| ||||
± Total n in this row equals 60 – one participant did not answer about gender.
a Chi-square test.
b Fisher’s exact test.